Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer

AUTOR(ES)

Zhang, Y., Chen, Q.

FONTE

Braz J Med Biol Res

DATA DE PUBLICAÇÃO

18/05/2017

RESUMO

Ovarian cancer is one of the most malignant genital cancers, with a high mortality rate. Many researchers have suggested that matrix metalloproteinases (MMPs) have remarkably high expression in ovarian cancer tissues. MMPs are considered to be related to the occurrence, development, invasion and metastasis of ovarian cancer. Moreover, some studies have discovered that the unbalance between MMPs and tissue inhibitor of metalloproteinases (TIMPs) are associated with the malignant phenotype of tumors. This review summarizes the latest research progress of MMPs in ovarian cancer. The investigation of MMP mechanism in ovarian cancer will facilitate the development of effective anti-tumor drugs, and thereby improve the survival rate of patients with ovarian cancer.

Documentos Relacionados

• Role of matrix metalloproteinases in the development of airway inflammation and remodeling
• Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer
• Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer
• Matrix Metalloproteinases As Novel Biomarkers and Potential Therapeutic Targets in Human Cancer
• THE RELATIONSHIP BETWEEN TRAUMA AND CANCER